CD4 and liver cancer: Recent research in CD4+ T cells has shown that MATR3, as a key regulator of CD4+ T cell function in a liver cancer model, recruits the ARID1A-containing cBAF complex to enhance chromatin accessibility at the TOX promoter region, thereby exacerbating CD4+ Tex (33).